Karen Andersen, CFA, is a healthcare strategist for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She is r ...

Oculis intends to use the net proceeds from the Offering to advance and accelerate its clinical development pipeline, particularly the development of its novel neuroprotective clinical candidate ...

Bitcoin (BTC) managed to put in a modest rally early in the U.S. trading session on Friday, but the move was quickly snuffed ...

The 2020 B. Keast Investment Trust (the "Trust") announced that on February 10, 2025, it completed an acquisition (the "Acquisition") from B. Keast Family Holdings Inc. ("KFH" or the "Seller") ...

The information on the calendar is subject to change at any moment and without prior notification. Users should verify the data independently and exercise due diligence in their financial activities.

Precigen has a market cap of $468mn and a cash runway into 2026, but needs more funds for commercialization. Check out my ...

Somehow, in between running multiple companies, gutting the federal bureaucracy, apparently cheating at video games and being ...

Objective Neural tube defects (NTDs) are a preventable folate deficiency disorder; increasing folic acid intake through food ...

Restrata, the operational resilience software and service provider to global enterprises, including some of the world’s largest energy and industrial companies, has raised investment from Scottish ...

Terns Pharmaceuticals' TERN-701 and TERN-601 face challenges in CML and obesity. Find out why TERN stock is not a strong buy amid tough competition.

Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half of ...